HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshihiko Tsukada Selected Research

Neoplasm Metastasis (Metastasis)

1/2003Surgical approach to tumor recurrence and metastatic lesions of the liver in a patient with malignant endocrine tumors of the pancreas: case report.
10/2002Menin, the multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presence of the tumor metastasis suppressor nm23.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshihiko Tsukada Research Topics

Disease

7Neoplasms (Cancer)
07/2014 - 10/2002
4Multiple Endocrine Neoplasia Type 1
08/2004 - 10/2002
3Primary Hyperparathyroidism
01/2010 - 03/2004
2Hypercalcemia (Milk Alkali Syndrome)
11/2009 - 04/2004
2Extraskeletal Myxoid Chondrosarcoma
10/2008 - 01/2002
2Genetic Translocation (Chromosomal Translocation)
10/2008 - 01/2002
2Cachexia
01/2004 - 02/2003
2Melanoma (Melanoma, Malignant)
01/2004 - 02/2003
2Body Weight (Weight, Body)
01/2004 - 02/2003
2Neoplasm Metastasis (Metastasis)
01/2003 - 10/2002
1Prolactinoma (Prolactinomas)
03/2012
1Osteitis Fibrosa Cystica
11/2009
1Parathyroid Neoplasms (Parathyroid Neoplasm)
11/2009
1Autoimmune Diseases (Autoimmune Disease)
10/2009
1Atopic Dermatitis (Atopic Eczema)
01/2005
1Hypertension (High Blood Pressure)
04/2004
1Hyperaldosteronism (Conn Syndrome)
04/2004
1Adrenocortical Adenoma (Disease, Conn's)
04/2004
1Breast Neoplasms (Breast Cancer)
04/2004
1Carcinogenesis
03/2004
1Secondary Hyperparathyroidism
03/2004
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2003
1Weight Loss (Weight Reduction)
02/2003
1Weight Gain
02/2003
1Hypoparathyroidism
06/2002
1Hypocalcemia
06/2002

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
01/2010 - 10/2002
3Orphan Nuclear ReceptorsIBA
10/2008 - 01/2002
2Parathyroid Hormone (Parathormone)IBA
11/2009 - 03/2004
2CalciumIBA
04/2004 - 06/2002
2Messenger RNA (mRNA)IBA
01/2004 - 02/2003
2Peptides (Polypeptides)IBA
01/2004 - 02/2003
2LeptinIBA
01/2004 - 02/2003
2GhrelinIBA
01/2004 - 02/2003
1liu-jun-zi-tangIBA
07/2014
1Dopamine Agonists (Dopamine Agonist)IBA
03/2012
1Protein Isoforms (Isoforms)IBA
03/2012
1RNA IsoformsIBA
03/2012
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
03/2012
1ProlactinIBA
03/2012
1Cyclin-Dependent Kinase Inhibitor p15IBA
01/2010
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2010
1Caspase 8 (Caspase-8)IBA
01/2010
1Immunoglobulin E (IgE)IBA
10/2009
1Core Binding Factor alpha SubunitsIBA
10/2009
1UbiquitinIBA
08/2004
1Proteasome Endopeptidase Complex (Proteasome)IBA
08/2004
1PotassiumIBA
04/2004
1Spironolactone (Aldactone)FDA LinkGeneric
04/2004
1AldosteroneIBA
04/2004
1Nifedipine (Adalat)FDA LinkGeneric
04/2004
1Transforming Growth Factor beta (TGF-beta)IBA
03/2004
1Transforming Growth Factors (Transforming Growth Factor)IBA
03/2004
1Blood Glucose (Blood Sugar)IBA
01/2004
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2004
1Nonesterified Fatty Acids (NEFA)IBA
01/2004
1DNA (Deoxyribonucleic Acid)IBA
05/2003
1Anabolic AgentsIBA
02/2003
1NucleosidesIBA
10/2002
1Guanosine Triphosphate (GTP)IBA
10/2002
1NM23 Nucleoside Diphosphate KinasesIBA
10/2002
1Diphosphates (Pyrophosphates)IBA
10/2002
1MagnesiumIBA
06/2002
1Calcium-Sensing ReceptorsIBA
06/2002

Therapy/Procedure

1Therapeutics
01/2010
1Mastectomy (Mammectomy)
04/2004
1Pancreaticoduodenectomy
01/2003
1Pancreatectomy
01/2003
1Gastrectomy
01/2003
1Segmental Mastectomy (Lumpectomy)
01/2003